Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0034063 (
pulmonary edema
)
10,665
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mice given lipopolysaccharide (LPS) intravenously developed
lung edema
, which was maximum after 6 h. Tumor necrosis factor, interleukin 12 (IL-12), IL-6, and interferon-gamma (IFN-gamma) appeared in the serum, and levels of nitrogen oxide (NO) derivatives were increased in serum and bronchoalveolar fluid. Mice pretreated with neutralizing anti-IFN-gamma antibodies had lower serum levels of IFN-gamma, and fewer died. However, levels of other cytokines and NO derivatives as well as
lung edema
were unchanged. If IFN-gamma and LPS were given together,
pulmonary edema
was less, but levels of cytokines and NO derivatives in serum were raised, and the mortality was greater. IFN-gamma receptor knockout mice had more edema after LPS, but were less sensitive to the lethal effects. Treatment with anti-IL-12 antibody inhibited IFN-gamma induction and reduced mortality, but had no effect on the
lung edema
; exogenous IL-12 also failed to affect edema, but boosted serum cytokine levels and increased the mortality.
Aminoguanidine
, an inhibitor of NO synthase, protected against
pulmonary edema
, but did not modify the lethal effects of LPS. Clearly, in this model, early
pulmonary edema
and lethality are not directly related, and induced IFN-gamma has no role in causing early
lung edema
, but augments other events that result in death.
...
PMID:Role of interferon-gamma and nitric oxide in pulmonary edema and death induced by lipopolysaccharide. 1061 6
The preventive and curative action of NO-synthase inhibitors derived from L-arginine was investigated on the model of toxic
lung edema
induced by phosgene (LCt50 - 84) in mice. The most pronounced decrease in the phosgene-induced
lung edema
was observed for aminoguanidine, NG-nitro-L-arginine (L-NNA), and L-nitroarginine methyl ester (L-NAME).
Aminoguanidine
was effective in cases of both preventive and curative administration. L-NNA, an inhibitor of the constitutive isoform of NO-synthase, was effective only after preventive injection, while L-NAME, an inhibitor of both inducible and constitutive isoforms of NO-synthase, was effective only after curative use. Therefore, the NO-synthase inhibitors are a promising group of pharmacological agents for the treatment of toxic
lung edema
induced by phosgene.
...
PMID:[Using NO-synthase inhibitors derived from L-arginine for preventing acute experimental lung edema development in mice]. 1944 29